Steve Brozak
Steve Brozak | |
|---|---|
| Born | 1961 New York City, New York, U.S. |
| Alma mater | Columbia University School of General Studies Columbia Business School Drew University |
| Occupation(s) | President of WBB Securities, LLC; Financial Analyst; Investment Banker |
| Template:Infobox military person | |
Steve Brozak (born 1961) currently serves as Managing Partner and President of WBB Securities, LLC. He was a Democratic candidate for Congress in 2004 and previously held the position of Chairman and CEO at StormBio, Inc. In 2013, Thomson Reuters recognized him as a StarMine "Top Stock Picker" among Pharmaceutical Analysts, and The Wall Street Journal honored him as "Best on the Street" for his analysis in Medical Equipment and Supplies. Brozak is a retired Lieutenant Colonel in the United States Marine Corps and participated on the Secretary of Navy's Navy and Marine Corps Retiree Council. Additionally, he is a Fellow of the Foreign Policy Association.
Education
Brozak earned his Bachelor of Arts degree from Columbia University in 1982, followed by an MBA from Columbia Business School in 1994. He later obtained a Doctorate in Medical Humanities (DMH) from Drew University in 2016.
Career
As co-founder and leader of WBB Securities, LLC, Brozak directs an independent broker-dealer, investment banking firm, and sell-side research organization that concentrates on healthcare sectors such as biotechnology, pharmaceuticals, and medical devices. The company is regularly acknowledged for its precise research output. In 2016, WBB broadened its operations by launching the WBB Life Sciences long/short equity healthcare fund within asset management.
In his role as president, Brozak manages both research and investment banking teams with an emphasis on capital raising efforts throughout various healthcare industries. Over a span of five years, he has been consistently ranked among the top healthcare analysts by StarMine and was recognized as a leading analyst in the U.S. Healthcare Sector by both Financial Times and StarMine in 2010. His areas of specialization include biotechnology, medical devices, pharmaceuticals, stem cell therapies, biothreat countermeasures, and infectious diseases such as influenza, Marburg virus, and Ebola.
Brozak is a frequent contributor to publications like Forbes, Businessweek, STAT, CNN, and ABCNews.com where he writes about healthcare innovation, pharmaceutical market trends, and policy developments. His insights have been extensively cited by major media outlets including Bloomberg, Financial Times, Reuters, and The Wall Street Journal. His public commentary also addresses critical health issues such as pandemic influenza preparedness and reforms within the U.S. healthcare system.
He held the position of Associate Producer for Money for Nothing: Inside the Federal Reserve (2013) and Executive Producer for American Veteran (2017).
Previously, Brozak served as Chairman and CEO at StormBio, Inc., a biotechnology firm focused on developing treatments aimed at cytokine storm to lower mortality rates from highly virulent influenza strains like H5N1 and H1N1. StormBio’s work centered on controlling excessive inflammatory responses linked to severe flu infections and related inflammatory diseases. The company partnered with prominent inflammation researchers and possessed licensed intellectual property targeting pandemic influenza therapeutics.
Political career
During his 2004 run for Congress, Brozak attracted significant attention when the Wall Street Journal featured him on its front page, spotlighting his concerns over U.S. troop shortages in Iraq and his call for a revised approach to achieve regional stability. His campaign focused on the inadequate planning behind the Iraq conflict, the military’s overextension, and the economic consequences, including increased energy costs. Additionally, he advocated for stem cell research advancement and equitable trade policies. Salon characterized his campaign as "a referendum on Bush's military folly."
At the 2004 Democratic National Convention, Brozak delivered a prime-time speech sharply criticizing the Bush administration's failures in prewar strategy. He received pushback from The Weekly Standard for his stance against politically motivated Pentagon appointments. Ultimately, Brozak lost to incumbent Republican Mike Ferguson in New Jersey’s 7th Congressional District.
Military service
Brozak retired as a Lieutenant Colonel in the United States Marine Corps, with deployments spanning Europe, the Middle East, Asia, and the Caribbean. His assignments included roles as a Foreign area officer at the U.S. Mission to the United Nations, as well as serving as Public Information Officer during the United Nations Mission in Haiti (UNMIH). He also collaborated with NATO and the Inter-American Defense Board.
Following the September 11 attacks in 2001, Brozak returned to active duty as Officer in Charge of Mobilization Training Unit NY-17 based in New York City. Subsequently, he led an evaluation team during Operation Enduring Freedom assessing mobilization efforts of National Guard and Reserve forces in the Middle East. Their findings underscored critical troop shortages and the heavy demands placed on reserve components due to deployments in Iraq and Afghanistan. Prior to retirement, he held the position of Chief Spokesperson for the OSD's National Committee for Employer Support of the Guard and Reserve in Washington D.C. Brozak also represented Navy and Marine Corps retirees on the SECNAV Retiree Council and earned two Navy/Marine Corps Meritorious Service Medals, including recognition for his contributions in Washington.
Personal background
Born in 1961, Brozak is married with two children and lives in Westfield, New Jersey.
Selected publications
- "Does the GI Bill Even Work" CNN, November 11, 2014
- "Why the Ebola Crisis Won't End Without Military Intervention" Businessweek, September 16, 2014
- "A 21st Century Nosocomial Issue with Endoscopes" British Medical Journal, March 19, 2014
- "Meningitis Outbreak: Restoring Confidence in the Drug Industry" ABC News, October 16, 2012
- "A Case for Accelerating Regenerative Medicine" ABC News, April 12, 2012
- "A New American 11/11/11 Day: The Health Care Veterans Deserve" ABC News, November 11, 2011
- "Seeking Innovation: Incentive Funding for Biodefense Biotechs" Biosecurity and Bioterrorism: Biodefense Strategy, Practice and Science Volume 8, Number 4, 2010
- "Long Shadow of the Stem-Cell Ruling" Nature, Volume 467, 1031–1033 (October 28, 2010)
- Fukushima and Nuclear Power: Playing with Fire ABC News, April 25, 2011
- Fukushima: A Nuclear Threat to Japan, the U.S. and the World ABC News, April 6, 2011
- Fukushima Joins Titanic, Katrina as a Single Word for Disaster ABC News, March 16, 2011
- "Winners and Losers of the Greek Financial Crisis" abcnews.com. May 12, 2010
- "Four Standard-Bearers For Stem Cell Therapies" Forbes.com. April 23, 2010
- "How the Euro's Woes Could Affect Economic and Individual Health" abcnews.com. February 25, 2010
- "The Facts Versus the Truth about Swine Flu" abcnews.com. September 3, 2009
- "Attack of the Zombie Biotechs" Forbes.com. April 2, 2009
- "Why Your Health Care Is in Jeopardy" abcnews.com. February 19, 2009
- "Caution - The FDA Could Be Hazardous to Your Health" Food and Drug Law Journal. January/February 2009
- "The Future of the FDA in the Next Administration" abcnews.com. October 27, 2008
- "The China Syndrome" abcnews.com. June 15, 2007
- "War Is a Force that Gives Us Meaning" Book Review Marine Corps Gazette. August 2003
- "The Marine Corps, the media, and the 21st century" Marine Corps Gazette. January 2002